Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23326039 | 0.83 | ADH1C (0.32) | ADH1AADH1C | |
| SCHEMBL6062935 | 0.81 | ADH1A (0.39) | ADH1AADH1C | |
| SCHEMBL21655360 | 0.80 | — | — | |
| SCHEMBL29234274 | 0.79 | CYP1A2 (0.34) | ADH1AADH1C | |
| SCHEMBL20228481 | 0.79 | — | — | |
| SCHEMBL20228495 | 0.78 | ADH1A (0.35) | ADH1AADH1C | |
| SCHEMBL6061772 | 0.77 | ADH1A (0.39) | ADH1AADH1C | |
| SCHEMBL19968446 | 0.75 | ADH1C (0.31) | ADH1AADH1C | |
| SCHEMBL20033665 | 0.68 | ADH1A (0.42) | ADH1AADH1C | |
| SCHEMBL810840 | 0.67 | PHGDH (0.37) | ADH1AADH1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10981156-B2 | Chromium complex and catalyst therefrom | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-04-20 | — | — | US | disclosed |
| US-20190210013-A1 | CHROMIUM COMPLEX AND CATALYST THEREFROM | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10981156-B2 | Chromium complex and catalyst therefrom | OXER1, LIG1, PICALM | ADH1A 3067/4885ADH1C 2335/4885 |
| US-20190210013-A1 | CHROMIUM COMPLEX AND CATALYST THEREFROM | OXER1, LIG1, PICALM | ADH1A 3067/4885ADH1C 2335/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.